Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
84.80
+1.12 (1.34%)
After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Cash & Equivalents
2,4462,9382,6863,2733,1413,0453,6761,6451,2251,1321,4101,043872.57691,2481,1981,031862.81,5071,313
Short-Term Investments
1,2261,2881,156789.4757.9930.7769.7345.3473500.5453.8466.7381.7446.3490.9317.7465604287.8248.4
Cash & Short-Term Investments
3,6724,2263,8424,0623,8993,9764,4461,9901,6981,6331,8641,5091,2541,2151,7391,5161,4961,4671,7951,561
Cash Growth (YoY)
-5.82%6.30%-13.59%104.15%129.65%143.50%138.54%31.84%35.35%34.35%7.20%-0.43%-16.16%-17.15%-3.12%-2.91%12.42%4.58%38.55%34.15%
Accounts Receivable
775.7659.6693.3697669.2609.1716778.3817.6771.5739.8754.4717.7643618.1636.4636.3582.2600.6640.5
Other Receivables
197.3252.5199.5205.682.7118.395.556.159.356.662.3--56.143.342.849.982.763.659.8
Total Trade Receivables
973912.1892.8902.6751.9727.4811.5834.4876.9828.1802.1754.4717.7699.1661.4679.2686.2664.9664.2700.3
Inventory
1,1191,1261,1411,1421,1141,0871,1041,0251,207903.51,032980.2914.3875.5757.8740730.6726.7737.8759.5
Other Current Assets
465.2474.3483.2470.7448.4495.4365.9667.1388.7353.7369.1340.6309.4305.9356328.1328.6322.3318.8301.9
Total Current Assets
6,2296,7396,3596,5776,2136,2856,7284,5164,1714,0364,0683,6473,2573,0963,5143,2633,2413,1813,5163,323
Net Property, Plant & Equipment
1,9221,9151,8401,8261,7951,7841,7801,7331,8661,6751,7721,7471,7351,7251,6541,6441,6421,6391,5491,530
Other Intangible Assets
1,2281,1281,1311,1731,1751,177956.1417.1446.8399.4429.8431.4446.8285.2266.5320.7322323.6325.3327
Goodwill
1,8201,7691,7691,7771,7791,7771,6051,1511,2531,1451,2971,3001,3081,1641,1591,1641,1661,1681,1701,172
Long-Term Investments
285.6278.6274.7298.5277.9307.9319.6353.3455.6583.9704.6856.21,0671,2391,3811,4911,6241,8341,2821,014
Other Long-Term Assets
1,8371,8681,9001,8381,7831,7251,5821,9291,5441,5241,0991,023837.6783.1664542.3424.3357.5317.7295.8
Total Assets
13,32113,69713,27213,48913,02213,05512,97110,0999,7369,3639,3719,0048,6518,2938,6388,4258,4208,5038,1607,662

Liabilities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Accounts Payable
181.1227.5165162.1172.4197.4172.8185.9212.3186.6190.6193180.8201.9154.9162.5158.8204.5139.5861.1
Accrued Expenses
1,2041,5621,3941,2141,1961,2821,745902.4873.7856.41,024939.9876.1795739.5783.3767.2802.3802.8-
Current Portion of Leases
24.324.526.825.923.723.424.221.524.822.924.324.325.125.523.523.323.925.524.225.1
Other Current Liabilities
--2.32.32.321.8107.2-129.5----------
Total Current Liabilities
1,4091,8141,5881,4051,3951,5051,9441,2171,1111,1951,2391,1571,0821,022917.9969.1949.91,032966.5886.2
Long-Term Debt
598.5598.3598.2598597.8597.7597.5597.3597.2597596.8596.7596.5596.3596.2596595.9595.7595.5595.4
Long-Term Leases
80.182.675.378.777.978.98574.277.265.27063.566.269.567.163.568.469.164.463.7
Other Long-Term Liabilities
906.1865805.7800.8760.2810.6733.2706.2764.7786.2764.2740.1844.5797.6839.2852.9960.8969.6992.6983.5
Total Long-Term Liabilities
1,5851,5461,4791,4781,4361,4871,4161,3781,4391,4481,4311,4001,5071,4631,5031,5121,6251,6341,6531,643
Total Liabilities
2,9943,3603,0672,8822,8312,9923,3602,5952,5502,6442,6442,5582,5892,4862,4202,4822,5752,6672,6192,529

Shareholders' Equity

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Common Stock
660658.7658.2657.6655.9654.8654.3653.5651.8650.5649.9649.1647.1646.3645.7645642.9642641.2640.1
Treasury Stock
-7,514-7,092-7,050-6,456-6,451-6,192-6,090-5,183-5,025-5,025-4,576-4,401-4,394-4,144-3,278-3,178-2,823-2,417-2,320-2,319
Additional Paid-in Capital
2,7822,7682,6972,7502,6532,6132,4522,4762,3802,2742,2112,1462,0491,9691,9151,8531,7691,7001,6431,579
Accumulated Other Comprehensive Income
-221.3-238.3-250.4-264.1-254.5-244.5-252.5-220.2-233.3-242.8-250.1-255.5-255.4-254.9-256-224.4-186.6-157.7-155.4-159.6
Retained Earnings
14,62114,24114,14913,85813,52513,16712,7819,7119,3448,9928,6238,2387,9317,5907,1926,8486,4426,0685,7335,393
Total Common Shareholders' Equity
10,32810,33810,20510,54510,1299,9989,5467,4377,1186,6506,6586,3765,9785,8076,2185,9445,8455,8365,5415,133
Minority Interest
---61.262.964.565.867.268.569.469.670.884-------
Shareholders' Equity
10,32810,33810,20510,60710,1929,9989,6117,5057,1866,7196,7276,4476,0625,8076,2185,9445,8455,8365,5415,133
Total Liabilities & Equity
13,32113,69713,27213,48913,02213,05512,97110,0999,7369,3639,3719,0048,6518,2938,6388,4258,4208,5038,1607,662

Additional Metrics

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Total Debt
702.9705.4700.3702.6699.4700706.7693699.2685.1691.1684.5687.8691.3686.8682.8688.2690.3684.1684.2
Net Cash (Debt)
2,9693,5213,1423,3603,1993,2763,7391,297998.4947.71,173824.8566.45241,052833807.7776.51,111877
Net Cash Growth (YoY)
-7.21%7.48%-15.98%159.07%220.42%245.67%218.84%57.23%76.27%80.86%11.49%-0.98%-29.88%-32.52%-5.29%-5.02%13.94%9.72%83.51%82.97%
Net Cash Per Share
5.116.055.365.715.445.556.252.151.651.561.921.350.930.851.681.331.281.231.761.39
Book Value
10,32810,33810,20510,54510,1299,9989,5467,4377,1186,6506,6586,3765,9785,8076,2185,9445,8455,8365,5415,133
Book Value Per Share
17.7817.7717.4217.9417.2316.9315.9612.3111.7810.9610.9210.459.799.429.969.489.299.238.778.15
Tangible Book Value
7,2807,4417,3067,5967,1757,0456,9845,8695,4185,1064,9304,6454,2234,3574,7934,4594,3574,3444,0463,635
Tangible Book Value Per Share
12.5412.7912.4712.9212.2111.9311.689.718.978.418.097.616.917.077.677.116.926.876.405.77
SEC Filings: 10-K · 10-Q